ACR: American College of Rheumatology

Conference Coverage

Combination therapy may boost remission in JIA

Study shows early methotrexate plus a biologic may aid remission and disease inactivity in pediatric polyarticular juvenile idiopathic arthritis...

Conference Coverage

Remibrutinib safe for Sjögren’s in phase 2

Results show the Bruton tyrosine kinase inhibitor has potential to become the first effective oral disease-modifying therapy for Sjögren syndrome...

Pages